MedTrace Logo

Task or Virtual Reality Intervention for Improving UE Function

NCT03811275 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 5

Last updated 2024-04-30

No results posted yet for this study

Summary

People with one arm that does not function well due to a stroke, head injury, or cerebral palsy, and a fully functional other arm, will be randomly assigned to receive one of the two interventions first, followed by the other intervention. The two interventions include a task-based intervention and a virtual reality intervention that provides a reflected image of the involved arm. The task-based intervention will consist of setting up activities of interest to be done using the involved arm and structuring practice and meaningful feedback to assist learning. The virtual reality intervention will consist of the person wearing the virtual reality device and practicing virtual tasks using the intact arm while seeing the involved arm. Intervention sessions will last approximately 30 minutes and will be held 3 times/week for 3 weeks each for a total of 9 sessions for each intervention. Testing of the involved arm's function will be done before the interventions, after receiving 9 sessions of each intervention, and one month after completing the second intervention received.

Conditions

  • Upper Extremity Paresis
  • Hemiplegia and/or Hemiparesis Following Stroke
  • Hemiplegic Cerebral Palsy

Interventions

BEHAVIORAL

Virtual Reality (A) then Task (B)

Participants will use their intact arm to perform virtual reality tasks while perceiving a reflected virtual image of their paretic arm.

BEHAVIORAL

Task (B) then Virtual Reality (A)

Participants will use their paretic arm to perform real tasks in a structured environment, with a practice and feedback schedule organized by a physical or occupational therapist, or graduate student.

Sponsors & Collaborators

  • Idaho State University

    lead OTHER

Principal Investigators

  • Nancy L Devine, PT, DPT, MS · Idaho State University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
89 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-09-08
Primary Completion
2024-04-26
Completion
2024-04-26

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03811275 on ClinicalTrials.gov